NasdaqGS:TSHABiotechs
Is It Too Late To Consider Taysha Gene Therapies (TSHA) After A 7x Three-Year Return?
For readers wondering if Taysha Gene Therapies at around US$5.95 is still offering value or if most of the opportunity is already reflected in the price, this article walks through what the current valuation actually implies.
The stock has shown sharp moves recently, with returns of 28.5% over 7 days, 30.2% over 30 days, 13.3% year to date and 379.8% over the last year. Over a 3 year period the return is around 7x, while the 5 year return shows a 74.3% decline.
Recent attention has focused...